Novartis AG (Novartis AG) Ending Cash Position : $9,469 Mil (As of Mar. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Novartis AG Ending Cash Position?

Novartis AG's Ending Cash Position for the quarter that ended in Mar. 2024 was $9,469 Mil.

Novartis AG's quarterly Ending Cash Position increased from Sep. 2023 ($12,405 Mil) to Dec. 2023 ($13,393 Mil) but then declined from Dec. 2023 ($13,393 Mil) to Mar. 2024 ($9,469 Mil).

Novartis AG's annual Ending Cash Position declined from Dec. 2021 ($12,407 Mil) to Dec. 2022 ($7,517 Mil) but then increased from Dec. 2022 ($7,517 Mil) to Dec. 2023 ($13,393 Mil).

Novartis AG Ending Cash Position Historical Data

The historical data trend for Novartis AG's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis AG Ending Cash Position Chart

Novartis AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

11,112.00

9,658.00

12,407.00

7,517.00

13,393.00

Novartis AG Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															12,000.00	10,885.00	12,405.00	13,393.00	9,469.00

Novartis AG Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Novartis AG's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	7517	+	5876
	=	13,393

Novartis AG's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	13393	+	-3924
	=	9,469

Novartis AG Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Novartis AG's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Novartis AG (Novartis AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (OTCPK:NVSEF) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

NVS:USA NVS N:Mexico NOVNz:UK 0QLR:UK NOTA:Germany NOTA:Germany NOVNEE:Switzerland NOVN:Switzerland N1VS34:Brazil NVS:Argentina

Address

Lichtstrasse 35, Basel, CHE, 4056

Website

https://www.novartis.com

Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.